Natsuko Onishi

Also affiliated with University of California System, University of San Francisco

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial”.

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03267-1

N/A

1.4DataRank · unranked

43 citations

Meghna S. Trivedi, Christina Yau, Rita Nanda, Hope S. Rugo, Marie Davidian +55 more

Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL

npj Breast Cancer(2020)10.1038/s41523-020-00203-7

N/A

0.666DataRank · unranked

84 citations

David C. Newitt, Jessica Gibbs, Lisa J. Wilmes, Ella F. Jones, Vignesh A. Arasu +57 more

Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer

Breast Cancer Research(2020)10.1186/s13058-020-01292-9

N/A

0.652DataRank · unranked

76 citations

Meredith Sadinski, Mary Hughes, Eun Sook Ko, Peter Gibbs, Katherine Gallagher +7 more

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03266-2

N/A

0.610DataRank · unranked

13 citations

Jane Meisel, Christina Yau, Hope S. Rugo, Rita Nanda, Marie Davidian +52 more

Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response

Radiology(2021)10.1148/radiol.2021203645

N/A

0.550DataRank · unranked

38 citations

Wen Li, David C. Newitt, Roy Harnish, Fredrik Strand, Alex Nguyen +56 more

Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer

Tomography(2020)10.18383/j.tom.2020.00016

N/A

0.489DataRank · unranked

25 citations

David C. Newitt, Bo La Yun, Ella F. Jones, Vignesh A. Arasu, Lisa J. Wilmes +8 more

Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial

Tomography(2020)10.18383/j.tom.2020.00006

N/A

0.434DataRank · unranked

17 citations

Wen Li, Jessica Gibbs, Lisa J. Wilmes, Alex Nguyen, Ella F. Jones +7 more

Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment

Radiology Imaging Cancer(2023)10.1148/rycan.220126

N/A

0.373DataRank · unranked

8 citations

Teffany Joy Bareng, Jessica Gibbs, Wen Li, Elissa R. Price, Bonnie N. Joe +93 more

MRI-Based Model for Personalizing Neoadjuvant Treatment in Breast Cancer

Tomography(2025)10.3390/tomography11030026

N/A

0.300DataRank · unranked

4 citations

Natsuko Onishi, Jessica Gibbs, Lisa J. Wilmes, Nu N. Le, Pouya Metanat +12 more

18F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy

Radiology Imaging Cancer(2024)10.1148/rycan.230082

N/A

0.208DataRank · unranked

3 citations

Natsuko Onishi, Deep Hathi, Courtney Lawhn-Heath, John Kornak, Wen Li +12 more

CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial

npj Breast Cancer(2025)10.1038/s41523-025-00830-y

N/A

0.104DataRank · unranked

1 citations

Karen S. Flatten, Taylor M. Weiskittel, Annapoorna Venkatachalam, Annabella R. Strathman, Olivia K. Rossman +17 more

Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy

Cancers(2022)10.3390/cancers14184436

N/A

0DataRank · unranked

23 citations

Nu N. Le, Natsuko Onishi, David C. Newitt, Lisa J. Wilmes, Jessica Gibbs +15 more

Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy

Tomography(2020)10.18383/j.tom.2020.00009

N/A

0DataRank · unranked

11 citations

Vignesh A. Arasu, Fredrik Strand, Wen Li, Natsuko Onishi, Jessica Gibbs +6 more

Denoising and Multiple Tissue Compartment Visualization of Multi‐b‐Valued Breast Diffusion MRI

Journal of Magnetic Resonance Imaging(2020)10.1002/jmri.27268

N/A

0DataRank · unranked

6 citations

Lisa J. Wilmes, Bonnie N. Joe, Natsuko Onishi, Vignesh A. Arasu, Nola M. Hylton +3 more

A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy

Breast Cancer Research(2020)10.1186/s13058-020-01291-w

N/A

0DataRank · unranked

99 citations

Natsuko Onishi, Duc Fehr, Brittany Z. Dashevsky, Meredith Sadinski, Katja Pinker +10 more

Effect of Inter-Reader Variability on Diffusion-Weighted MRI Apparent Diffusion Coefficient Measurements and Prediction of Pathologic Complete Response for Breast Cancer

Tomography(2022)10.3390/tomography8030099

N/A

0DataRank · unranked

7 citations

Wen Li, Natsuko Onishi, David C. Newitt, Jessica Gibbs, Lisa J. Wilmes +8 more

Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response

Tomography(2022)10.3390/tomography8020072

N/A

0DataRank · unranked

5 citations

Natsuko Onishi, Julia Carmona-Bozo, Wen Li, John Kornak, David C. Newitt +2 more